跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,461 条关于
“Inflammasome ASC Inhibitor”
全部
26,461
临床试验
12,661
药物
4,808
机构
145
资讯
8,847
去年
ZyVersa Highlights Data on Inflammasome Inhibition for Type 2 Diabetes Prevention
去年
ZyVersa Therapeutics to Present Kidney Disease Drug VAR 200 at JPM Healthcare Conference 2025
去年
ZyVersa's IC 100 Shows Promise as Disease-Modifying Treatment for Parkinson's Disease
去年
ZyVersa Therapeutics Initiates Phase 2a Trial for First-in-Class Diabetic Kidney Disease Treatment VAR 200
5年前
Novel NLRP3 Inflammasome Inhibitors Show Promise for Treating Multiple Inflammatory Diseases
去年
Halia Therapeutics Completes Enrollment in Phase 2a Trial of Novel NLRP3 Inflammasome Inhibitor for Myelodysplastic Syndrome
去年
NLRP3 Inflammasome Inhibition May Prevent Melanoma Hyper-Progression During Immunotherapy
去年
Error parsing response
去年
Inflammasome Therapeutics' K8 Implant Shows Promise in Geographic Atrophy Trial
7年前
Novartis Receives Patent for Novel NLRP3 Inflammasome Inhibitors with Potential for Multiple Inflammatory Diseases
第 1 页，共 885 页
上一页
下一页
